Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Debt to Assets Over TimeFair Value
Percentile Rank36
3Y CAGR-0.2%
5Y CAGR-0.1%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
-0.2%/yr
vs +4.9%/yr prior
5Y CAGR
-0.1%/yr
Consistent
Acceleration
-5.1pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthFair Value
PeriodValueYoY Change
20250.74+0.5%
20240.74-6.5%
20230.79+5.8%
20220.75+2.6%
20210.73-2.5%
20200.75-0.9%
20190.76+22.2%
20180.62-44.1%
20171.11+12.6%
20160.98-